Background: Supraclavicular brachial plexus block (SCB) is a common regional analgesic technique for upper limb fracture surgery, but it often leads to rebound pain. Our primary aim is to determine whether different administration methods of esketamine can reduce rebound pain in patients undergoing SCB for upper limb fracture surgery. Methods/design: This study is designed as a single-centre, double-blinded, prospective, randomised controlled trial. Patients undergoing upper limb fracture surgery, who plan to use a tourniquet, aged 18–60 years, with a body mass index of 18–30 kg/m 2 and an American Society of Anaesthesiologists classification of I–III will be randomised into three groups after providing written informed consent: group N (perineural esketamine/ropivacaine); group V (intravenous esketamine/perineural ropivacaine); and group C (perineural ropivacaine). The primary outcome will be the percentage of patients experiencing rebound pain within 24 hours postoperatively. Secondary outcomes include the Numeric Rating Scale (NRS) score of rebound pain, the onset of rebound pain, (since performing SCB), the cumulative area under the curve of NRS pain severity scores through 48 hours postsurgery, postoperative opioid consumption at 48 hours postoperatively, onset and duration of the sensory blockade, onset and duration of the motor blockade and adverse reactions and adverse events. Patients will be followed-up to 48 hours postoperatively. Discussions: This protocol describes the design of a randomised controlled trial to evaluate the effect of different modes of administration of esketamine combined with SCB on the incidence of rebound pain after upper limb fracture surgery. The results may help to identify the most effective methods for managing pain in patients undergoing upper limb fracture surgery. Ethics and dissemination: This study has been approved by the Ethics Committee of the Deyang People’s Hospital (2023-03-010-K01). It was registered on the Chinese Clinical Trials Registry on 24 August 2023. We intend to publish the results in a peer-reviewed journal. Trial registration number: ChiCTR2300075083.
BACKGROUND Previous studies have demonstrated that ozone injection into the dorsal root ganglion significantly reduces pain scores associated with herpes zoster, suggesting its therapeutic potential for managing postherpetic neuralgia (PHN) via the intervertebral foramen epidural space. However, there are no specific reports addressing the treatment of herpes zoster and PHN by involving the thoracic and lumbar nerves under computed tomography (CT) guidance. Our research focuses on the effect of medical ozone administered through the intervertebral foramen epidural space on PHN. OBJECTIVE This is a protocol for a prospective, randomized, controlled, and double-blind trial to detect whether the injection of medical ozone via the intervertebral foramen epidural space can reduce the incidence of PHN. METHODS After signing the written informed consent, patients meeting eligibility criteria will be allocated into the medical ozone group and the control group in a 1:1 ratio according to the randomized grouping information, with 35 patients in each group. Patients in both groups accepting the surgical procedure under CT guidance will be injected with 5 mL of therapeutic liquid. Subsequently, medical ozone (30 μg/mL, 5 mL in each segment) will be slowly administered in the medical ozone group versus a sham procedure in the control group. The primary outcome will be the incidence of PHN 3 months after the subsidence of rashes and vesicles. The secondary outcomes will be the times of injection treatment, complications during the surgical procedure, times of remedial analgesia with ultrasound-guided nerve block, numerical rating score and tactile sensation, Hospital Anxiety and Depression Scale score, and the use of lidocaine cataplasms and oral analgesics before and after the surgical procedure under CT guidance. Data analyses between the 2 groups will be compared using the 2-sided Student t test or Wilcoxon Mann-Whitney test based on the viability of the normality assumption, while chi-square or Fisher exact test will be used to compare the categorical data. RESULTS This study was approved by the medical ethics committee of Deyang People’s Hospital on February 27, 2024 (2024-03-002-K01). The first patient was enrolled on May 14, 2024. As of November 2024, 25 participants have been enrolled out of 70 who received screening. The analysis of the efficacy and safety data is expected to be performed in about May 2025 after all the patients have enrolled, with the approximate publication of results by September 2025. CONCLUSIONS If this exploratory trial proves effective, medical ozone administered via the intervertebral foramen epidural space may be utilized to aid in the recovery of the infected nerves and decrease the incidence of PHN in clinical settings. Positive outcomes will bolster the potential of employing medical ozone in the treatment of herpes zoster, thereby contributing to a reduction in the incidence of PHN. CLINICALTRIAL Chinese Clinical Trial Registry ChiCTR2400084014; https://tinyurl.com/jk6p9hn2 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/68847
22 June 2026 in Online Journal of Public Health Informatics
Background: China has initiated a national stroke program since 2011. Understanding the magnitude of stroke burden in China is crucial for modulating related policies. Objective: This study aimed to analyze stroke status in China from the 2023 Global Burden of Disease study. Methods: The 2023 Global Burden of Disease study was the source of the estimation of stroke burden. The data of deaths, incidence, prevalence, disability-adjusted life years (DALYs), years lived with disability (YLDs), and years of life lost attributable to stroke and its subtypes from 1990 to 2023 were analyzed. The mortality-to-incidence ratio was calculated to quantify the proportion of incident stroke cases that result in deaths. DALY decomposition analysis was applied to quantify how stroke burden has shifted between mortality and long-term disability over time. Sex-specific characteristics were also compared. Results: From 1990 to 2023, absolute stroke incidence (1.87-4.23 million) and prevalence (11.56-26.68 million) increased substantially, with ischemic stroke as the primary driver. Age-standardized incidence declined from 246.15 to 192.19 per 100,000 populations, while mortality significantly reduced from 302.72 to 92.83 per 100,000 populations. DALYs and years of life lost decreased 9.3% and 11%, respectively, while YLDs increased more than double. Mortality-to-incidence ratio fell for all subtypes except subarachnoid hemorrhage, indicating improved survival. Male individuals bore a heavier burden in total stroke and ischemic stroke, while subarachnoid hemorrhage showed female predominance in prevalence and YLDs. DALY decomposition revealed that YLDs contribution rose from 5.8% to 14.5%. Conclusions: From 1990 to 2023, despite declining age-standardized rates, stroke burden in China grew due to ischemic stroke and population changes. The shifting burden toward disability and persistent sex disparities highlights the need for tailored prevention, rehabilitation, and gender-specific interventions.
BACKGROUND Cardiopulmonary bypass (CPB) is a life-support technology widely used in surgery. Review articles reflect research advances in a certain topic or field within a certain period of time. AIM To perform a bibliometric analysis of the review articles that focused on CPB for cardiovascular surgery. METHODS This study was based on a bibliometric analysis. Data were acquired from the Web of Science and basic bibliometric parameters were analyzed and visualized using VOSviewer and Excel. RESULTS We identified 141 review articles on CPB. Generally, the number of publications increased, and most of them were published in the 2010s (n = 57, 40.4%) and the 2020s (n = 45, 31.9%). There were 113 (80.1%) narrative review articles, 21 (14.9%) meta-analysis studies and 7 (5.0%) systematic review papers. The United States (n = 25, 17.7%) and China (n = 21, 14.9%) were the leading countries in terms of publication number. The articles were published in 98 different journals. The Journal of Cardiothoracic and Vascular Anesthesia (n = 14, 10.0%) and Perfusion-United Kingdom (n = 11, 7.8%) were preferred by the authors. The high-frequency keywords included inflammatory response, children, acute kidney injury, meta-analysis and off-pump, except for CPB and cardiac surgery. Inflammatory response had the closest relationship with CPB during cardiac surgery. The complications of CPB, including inflammatory response, kidney injury and ischemia, caught lots of concern. CONCLUSION The rapid increase of review papers shows that the research on CPB in cardiac surgery is increasingly being emphasized by scholars and clinical staff worldwide. Meta-analysis has been widely conducted to analyze clinical controversies and further guide clinical practice. Strategies to improving the outcomes of patients undergoing cardiac surgery with CPB are the hot spots in this field.
1 February 2025 in Medical Devices: Evidence and Research
Introduction: Sedatives and anesthetics can modify airway tone and induce respiratory depression, exacerbating the gas exchange impairments associated with obesity. In obese patients undergoing gastrointestinal endoscopy, upper airway obstruction and hypoventilation are prevalent, leading to frequent occurrences of hypoxemia during the procedure. This study aims to investigate the effects of the nasopharyngeal airway in mitigating hypoxemia via alleviating upper airway obstruction in obese outpatients during painless gastrointestinal endoscopy procedure. Methods: This is a prospective single-center randomized controlled study. After signing the written informed consent, eligible outpatients scheduled for painless gastrointestinal endoscopy will be randomly allocated into the nasopharyngeal airway group (group N) and control group (group C), with 88 patients in each group. Patients in group N will undergo intubation of the nasopharyngeal airway prior to examination, whereas patients in group C will receive oxygen therapy through an endoscopic respiratory mask at a flow rate of 10 L/min during the procedure. All patients in two groups will receive propofol and opioids for procedural sedation. The primary outcome will be the incidence of hypoxemia. The secondary outcomes will be the incidence of epistaxis, suspended examination due to hypoxemia, manual ventilation, the times of attempt to nasopharynx airway insertion, duration of insertion of nasopharyngeal airway, tracheal/laryngeal mask intubation, adverse cardiovascular events, gastrointestinal complications, VAS score of nasopharynx pain after removing the nasopharyngeal airway, satisfaction score of patients, endoscopist and anesthesiologists. Discussion: This study evaluates the effects of nasopharyngeal airway insertion on hypoxemia caused by procedural sedation in obese patients undergoing gastrointestinal endoscopy. The results of this study are expected to provide evidence for the use of nasopharyngeal airway in obese outpatients. Trial Registration Number: ChiCTR2300078892.